 |
|
Spring Meeting 2009 Trial Reports |
|
Genitourinary Newsletter - April 2009 |
| ID |
Study Title |
Status |
|
IND.165 |
A Randomized Phase II Study of OGX-011 in Combination with Docetaxel and Prednisone or Docetaxel and Prednisone Alone
in Patients with Metastatic Hormone Refractory Prostate Cancer
MORE... |
Closed |
|
IND.167 |
Phase II Study Of BAY 43-9006 (NSC 724772) In Patients With Hormone Refractory Prostate Cancer
MORE... |
Closed |
|
BL.7 |
Randomized Phase III Study Comparing Paclitaxel/Cisplatin/Gemcitabine and Cisplatin/Gemcitabine in Patients with
Metastatic or Locally Advanced Urothelial Cancer without Prior Systemic Therapy
MORE... |
Closed |
|
BL.8 |
Randomized Phase III Trial Comparing Immediate versus Deferred Chemotherapy After Radical Cystectomy in Patients
with pT3-pT4, and/or N+M0 Transitional Cell Carcinoma (TCC) of the Bladder
MORE... |
Closed |
|
BL.10 |
MVAC in Organ-Confined Bladder Cancer Based on p53 Status
MORE... |
Closed |
|
BL.11 |
A Phase III Study of Iressa® in Combination with Intravesical BCG versus Intravesical BCG Alone in High Risk
Superficial Transitional Cell Carcinoma of the Bladder
MORE... |
Closed |
|
PR.3 |
Intergroup (NCIC CTG, CUOG, SWOG, MRC-UK) Phase III Randomized Trial Comparing Total Androgen Blockade versus Total
Androgen Blockade Plus Pelvic Irradiation in Clinical Adenocarcinoma of the Prostate
MORE... |
Closed |
|
PR.7 |
A Phase III Randomized Trial Comparing Intermittent versus Continuous Androgen Suppression for Patients with
Prostate-Specific-Antigen Progression in the Clinical Absence of Distant Metastases Following Radiotherapy for
Prostate Cancer
MORE... |
Closed |
|
PR.8 |
Study of Intermittent Androgen Deprivation in Patients with Stage D2 Prostate Cancer, Phase III
MORE... |
Closed |
|
PR.9 |
Phase III Clinical Trial for PT3 and/or Margin Positive Prostate Carcinoma Following Radical Prostatectomy
(RTOG: P0011)
MORE... |
Closed |
|
PR.10 |
Randomized Trial of Radical Prostatectomy versus Brachytherapy for Patients with T1c or T2a N0 M0 Prostate Cancer
(ACOSOG: Z0070)
MORE... |
Closed |
|
PR.10C |
Health-Related Quality of Life in Patients with Low Risk, Localized Prostate Cancer Randomized to Radical Prostatectomy
or Brachytherapy (ACOSOG: Z0071)
MORE... |
Closed |
|
PR.11 |
A Phase III Study of Active Surveillance Therapy Against Radical Treatment in Patients Diagnosed with Favourable Risk
Prostate Cancer (START)
MORE... |
Open |
|
PR.12 |
A Phase III Study of Neoadjuvant Docetaxel and Androgen Suppression plus Radiation Therapy versus Androgen Suppression
Alone plus Radiation Therapy for High-Risk Localized Adenocarcinoma of the Prostate (DART)
MORE... |
Closed |
|
PR.13 |
RADICALS: Radiotherapy and Androgen Deprivation In Combination After Local Surgery
MORE... |
Open |
|
PRC.2 |
A Randomized, Double-Blind, Placebo-Controlled Phase III Study of Early versus Standard Zoledronic Acid to Prevent
Skeletal Related Events in Men with Prostate Cancer Metastatic to Bone
MORE... |
Open |
|
PRC.3 |
A Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy versus
Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer
MORE... |
Open |
|
PRP.1 |
A Double-Blind, Placebo-Controlled, Randomized Study of Combination Vitamin E, Selenium and Soy Protein Product in
Subjects with High Grade Prostatic Intraepithelial Neoplasia
MORE... |
Closed |
|
PRP.1B |
An Investigation of Molecular and Genetic Risk Factors Associated with Development of Prostate Cancer in Subjects
with High Grade Prostatic Intraepithelial Neoplasia Treated with Placebo or Combination Vitamin E, Selenium and
Soy Protein Product
MORE... |
Closed |
|
REC.1 |
A Phase III Trial of Interferon-Alpha (IFNA) or IFNA Plus Bevacizumab in Advanced Renal Cell Cancer
MORE... |
Closed |
|
REC.2 |
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
MORE... |
Open |
